EGFR, epidermal growth factor receptor, 1956

N. diseases: 1394; N. variants: 183
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 AlteredExpression disease BEFREE Western blots and immunofluorescence showed expression of EGFR, EpoR and FGF in HEI-193, an immortalized cell line derived from human NF2-related VS. Matrigel invasion assays were used to study the effect of Epo, FGF and bFGF on invasive behavior in HEI-193. 21178801 2011
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 AlteredExpression disease LHGDN These findings implicate a functional role of ErbB-2 in the benign nature of VS and that a rationale for using ErbB targeted therapies in VS may be warranted. 17964790 2007
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 Biomarker disease BEFREE These data suggest an autocrine pathway of VS growth stimulation involving NRG and ErbB receptors. 16432850 2006
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 AlteredExpression disease BEFREE Our findings with immunohistochemistry and western blot analysis indicate a level of ErbB-1 similar to normal peripheral nerve, but a high expression of ErbB-2 similar to the vestibular schwannoma and glioblastoma multiforme. 20547458 2010
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 Biomarker disease LHGDN Activated epidermal growth factor receptor B (ErbB) 2 and ErbB3 are abundantly expressed in VS. ErbB2 signaling is essential for Schwann cell differentiation, survival, and proliferation. 18199957 2008
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 Biomarker disease BEFREE ErbB receptor phosphorylation was similarly examined in cultured schwannoma cells, normal Schwann cells, and VS tumor tissues using Western blotting. 22222570 2012